These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7693985)

  • 1. Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy.
    Cornel EB; Smits GA; Oosterhof GO; Karthaus HF; Deburyne FM; Schalken JA; Heerschap A
    J Urol; 1993 Dec; 150(6):2019-24. PubMed ID: 7693985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
    Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
    Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology.
    García-Segura JM; Sánchez-Chapado M; Ibarburen C; Viaño J; Angulo JC; González J; Rodríguez-Vallejo JM
    Magn Reson Imaging; 1999 Jun; 17(5):755-65. PubMed ID: 10372529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report.
    Narayan P; Jajodia P; Kurhanewicz J; Thomas A; MacDonald J; Hubesch B; Hedgcock M; Anderson CM; James TL; Tanagho EA
    J Urol; 1991 Jul; 146(1):66-74. PubMed ID: 1711587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR.
    Fowler AH; Pappas AA; Holder JC; Finkbeiner AE; Dalrymple GV; Mullins MS; Sprigg JR; Komoroski RA
    Magn Reson Med; 1992 May; 25(1):140-7. PubMed ID: 1375702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue.
    Heerschap A; Jager GJ; van der Graaf M; Barentsz JO; de la Rosette JJ; Oosterhof GO; Ruijter ET; Ruijs SH
    Anticancer Res; 1997; 17(3A):1455-60. PubMed ID: 9179183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coil.
    Kim JK; Kim DY; Lee YH; Sung NK; Chung DS; Kim OD; Kim KB
    Magn Reson Imaging; 1998 Dec; 16(10):1281-8. PubMed ID: 9858286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.
    Komoroski RA; Holder JC; Pappas AA; Finkbeiner AE
    Magn Reson Med; 2011 Apr; 65(4):911-3. PubMed ID: 20967792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic characterization of human prostate tissue with proton MR spectroscopy.
    Swindle P; McCredie S; Russell P; Himmelreich U; Khadra M; Lean C; Mountford C
    Radiology; 2003 Jul; 228(1):144-51. PubMed ID: 12832578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro high resolution 1H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma.
    Schiebler ML; Miyamoto KK; White M; Maygarden SJ; Mohler JL
    Magn Reson Med; 1993 Mar; 29(3):285-91. PubMed ID: 7680746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
    Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
    Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro proton spectroscopy of normal and abnormal prostate.
    Yacoe ME; Sommer G; Peehl D
    Magn Reson Med; 1991 Jun; 19(2):429-38. PubMed ID: 1715505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31P MR spectroscopy and 1H MR imaging of the human prostate using a transrectal probe.
    Hering F; Müller S
    Urol Res; 1991; 19(6):349-52. PubMed ID: 1722056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using endorectal 1H magnetic resonance spectroscopy].
    Saikawa S; Suzuki Y; Tomoi M; Yoshida M; Ishii Y; Okada K
    Nihon Hinyokika Gakkai Zasshi; 1995 Nov; 86(11):1673-80. PubMed ID: 8551711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate.
    Kumar R; Kumar M; Jagannathan NR; Gupta NP; Hemal AK
    Urol Res; 2004 Feb; 32(1):36-40. PubMed ID: 14534764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between benign prostatic hyperplasia and prostate cancer in the transitional zone evaluated by 1H magnetic resonance spectroscopic imaging.
    Li SY; Chen M; Wang R; Zhou C
    Chin Med Sci J; 2007 Dec; 22(4):238-42. PubMed ID: 18246671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.
    Averna TA; Kline EE; Smith AY; Sillerud LO
    J Urol; 2005 Feb; 173(2):433-8. PubMed ID: 15643195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance spectroscopy. A new technic for the study and the diagnosis of prostatic disease].
    García-Segura JM; Sánchez Chapado M
    Arch Esp Urol; 1995 Jun; 48(5):423-46. PubMed ID: 7543739
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra.
    Hahn P; Smith IC; Leboldus L; Littman C; Somorjai RL; Bezabeh T
    Cancer Res; 1997 Aug; 57(16):3398-401. PubMed ID: 9270004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.